A Prospective View on European Pharmaceutical Research and Development: Policy Options to Reduce Fragmentation and Increase Competitiveness

Author： Kanavos P.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.2, 1998-02, pp. : 181-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to increase trust in reporting pharmaceutical research findings

By Mark G. Brian H.

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 1, 2002-02 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness Research: The View from a Pharmaceutical Company

By Berger Marc L. Grainger David

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 915-922

Adis International

Access to resources Recommend Favorite

Purity as an issue in pharmaceutical research and development

By Bauer M. de Leede L. Van Der Waart M.

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 4, 1998-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite

Open innovation: the new face of pharmaceutical research and development

By Getz Kenneth A Kaitin Kenneth I

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 481-483

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review

By Mil J. Schulz Martin Tromp Th.

Pharmacy World and Science, Vol. 26, Iss. 6, 2004-12 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite